Collapse of feed-forward inhibition underpins hyperexcitability in GABAA receptor gain-of-function epilepsy
Brain · 04.11.2026 · 149 (11) · 3789-3805
DOI: 10.1093/brain/awag119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 22.04.2026. Verfasst von Chaseley E McKenzie und 22 weiteren Autor:innen. Beteiligte Einrichtung: The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria 3010, Australia. Hauptthemen laut MEDLINE: Receptors, GABA-A, Epilepsy, Neural Inhibition. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victorian State Government Operational Infrastructure Support, Australian Government National Health and Medical Research Council (NHMRC), Institute Infrastructure Support Scheme.
Abstract (Originalsprache)
Gain-of-function (GOF) variants in γ-aminobutyric acid type A (GABAA) receptors are increasingly recognized as a cause of severe developmental and epileptic encephalopathies. However, the mechanisms by which enhanced GABAA receptor activity leads to neuronal network hyperexcitability remain unclear. We engineered a new mouse model based on the human GOF GABRB3 p.(Glu77Lys) variant (β3E77K), identified in two individuals diagnosed with developmental and epileptic encephalopathies, to explore the mechanisms underlying GABAA receptor GOF disease. The phenotypes of β3E77K mice included embryonic lethality consistent with a severe early developmental impact of the GOF GABAA receptor variant. These mice display spike-wave-like discharges that were exacerbated by vigabatrin and ameliorated by valproate, matching the clinical observations of GOF GABRB3 patients. β3E77K mice also have increased proconvulsant-induced seizure susceptibility and a broad increase in electrocorticographic spectral power amplitude, indicative of cortical hyperexcitability. Additionally, neurological assessments revealed hypoactivity and weakened grip strength. Ex vivo electrophysiological recordings demonstrated increased GABAA receptor-mediated current amplitudes at both excitatory and inhibitory synapses in CA1 hippocampus, consistent with the GOF molecular phenotype previously identified in functional studies. In cortical layer 2/3, inhibitory interneurons showed increased synaptic GABAA receptor-mediated current amplitude, and synapses onto pyramidal neurons exhibited reduced inhibitory currents. Enhanced GABAA receptor-mediated synaptic activity among layer 2/3 interneuron populations caused a use-dependent collapse of feed-forward inhibition, resulting in increased pyramidal neuron excitability. Computational modelling supported this disinhibition mechanism, showing that enhanced GABAA receptor synaptic strength between interneurons diminishes inhibitory synaptic conductance onto pyramidal cells. Our findings highlight the critical role of interneuron network dysfunction in driving cortical hyperexcitability caused by GOF GABAA receptor variants. They provide a novel pathogenic mechanism in developmental and epileptic encephalopathies that could have broader implications for disorders involving dysfunction in GABAergic neurons. The β3E77K mouse also provides a unique preclinical model to test therapeutic strategies in GOF GABAA receptor disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria 3010, Australia.
- Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
- Brain and Mind Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales 2006, Australia.
- Department of Neurology, Eastern Health, Victoria 3128, Australia.
- Centre for Eye Research Australia, University of Melbourne, Victoria 3002, Australia.
- Life Sciences Center, Vilnius University, Vilnius LT-10257, Lithuania.
ORCID-Profile: Chaseley E McKenzie, Anthony S H Kan, Ming S Soh, Rikke S Møller, Jean-François Perrier, Philip K Ahring
Förderung
- Victorian State Government Operational Infrastructure Support
- Australian Government National Health and Medical Research Council (NHMRC)
- Institute Infrastructure Support Scheme
- NHMRC
- Lundbeck
Zitieren
APA
McKenzie, C. E., Aung, K. P., Dos Santos, A. B., Mao, M., Spyrou, J., Bryson, A., Wong, R., Lin, S. X. N., Bleakley, L. E., Palmqvist, J., Guzulaitis, R., Kan, A. S. H., Liao, V. W. Y., Soh, M. S., Gomez, C. D., Larsen, V., Petersen, A. M. N., Absalom, N. L., Møller, R. S., …, & Reid, C. A. (2026). Collapse of feed-forward inhibition underpins hyperexcitability in GABAA receptor gain-of-function epilepsy. Brain, 149(11), 3789-3805. https://doi.org/10.1093/brain/awag119
Vancouver
McKenzie CE, Aung KP, Dos Santos AB, Mao M, Spyrou J, Bryson A, et al. Collapse of feed-forward inhibition underpins hyperexcitability in GABAA receptor gain-of-function epilepsy. Brain. 2026;149(11):3789-3805. doi:10.1093/brain/awag119
BibTeX
@article{McKenzie2026,
author = {McKenzie, Chaseley E and Aung, Khaing Phyu and Dos Santos, Altair Brito and Mao, Miaomiao and Spyrou, James and Bryson, Alexander and Wong, Raymond and Lin, Susan X N and Bleakley, Lauren E and Palmqvist, Joakim and Guzulaitis, Robertas and Kan, Anthony S H and Liao, Vivian W Y and Soh, Ming S and Gomez, Carlos Daniel and Larsen, Victor and Petersen, Anne Marie Nordvig and Absalom, Nathan L and Møller, Rikke S and Chebib, Mary and Perrier, Jean-François and Ahring, Philip K and Reid, Christopher A},
title = {Collapse of feed-forward inhibition underpins hyperexcitability in GABAA receptor gain-of-function epilepsy},
journal = {Brain},
year = {2026},
volume = {149},
number = {11},
pages = {3789--3805},
doi = {10.1093/brain/awag119}
}
EUVIMED